Clinical Trial Update: Iadademstat in Combination With Azacitidine and Venetoclax in Treating Newly Diagnosed Acute Myeloid Leukemia [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating iadademstat in combination with azacitidine and venetoclax for newly diagnosed acute myeloid leukemia; recruitment is ongoing.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia
• Myelodysplastic Syndromes

Drugs mentioned

• AZACITIDINE (AZACITIDINE)
• Iadademstat (iadademstat)
• Venetoclax (venetoclax)

Snippet

Sponsor: OHSU Knight Cancer Institute | Conditions: Acute Myeloid Leukemia, Myelodysplastic Syndrome/Acute Myeloid Leukemia | Phase 1 | Status: RECRUITING